hepatitis-c-virus

Documents about hepatitis-c-virus

• A Novel Hepatitis c micrOelimination Program in Non imprisonEd SenTenced With Alternative Measures#863509ClinicalTrials.gov
• Evaluating Pay-It-Forward Strategy to Promote Hepatitis B Virus and Hepatitis C Virus Testing Among International Migrants From Low- and Middle-Income Countries in China: Protocol for a Cluster Randomized Controlled Trial.#219143NCBI PubMed Central
• A retrospective cohort data-linkage study of secondary healthcare use prior to late blood-borne virus diagnosis in Scotland – A missed opportunity for earlier diagnosis?#990058STORRE
• Seroprevalence of hepatitis C virus among refugees, asylum seekers, and internally displaced populations within Africa: A systematic review and meta-analysis.#9857PubMed
• Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment#67801ClinicalTrials.gov
• Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) Recipients#968748ClinicalTrials.gov
• Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures#1033025ClinicalTrials.gov
• A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C#859601ClinicalTrials.gov
• An entropic safety catch controls Hepatitis C virus entry and antibody resistance#329299Birkbeck Institutional Research Online
• HIV, Age, and the Severity of Hepatitis C Virus–Related Liver Disease#383966CiNii
• The Epidemic Status and Development Trend of Hepatitis C Virus Infection in Pregnant Women in Xi'an#830815ClinicalTrials.gov
• Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection#906420ClinicalTrials.gov
• The Use of Human Liver Chimeric Mice to Study Hepatitis C Virus Antibody Escape: Implications for Vaccine Development#295598PubMed Central
• Cross-Sectional Analysis Of The Hepatitis C Care Cascade Among People Who Use Drugs In New Haven, Ct#401531EliScholar
• Ledipasvir/Sofosbuvir Fixed-Dose Combination and Vedroprevir With or Without Ribavirin in Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection and Cirrhosis#813372ClinicalTrials.gov
• Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 or 24 Weeks in Genotype 1 or 4 HCV Infected Adults With Sickle Cell Disease#900963ClinicalTrials.gov
• Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) in Patients Who Have Previously Not Received the Standard of Care#901015ClinicalTrials.gov
• Plasma-targeted proteomic and lipidomic profiling of MASLD, MASH, and hepatitis C virus infection.#193728NCBI PubMed Central
• sgp130 in Chronic Human Liver Disease#804318ClinicalTrials.gov
• Sovaldi-based Regimens in Patients in Mexico With Chronic Hepatitis C Virus Infection in Clinical Practice#881280ClinicalTrials.gov
• Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting#891094ClinicalTrials.gov
• Safety and Efficacy Study of Pegylated Interferon Lambda With and Without Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3#852567ClinicalTrials.gov
• Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis#853429ClinicalTrials.gov
• TMC435-TiDP16-C114 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents TMC278 and Tenofovir#893806ClinicalTrials.gov
• Study of Long-term Peg Intron vs. Colchicine in Non-responders.#67753ClinicalTrials.gov
• A novel dimerization site in non-structural protein 5A of hepatitis C virus regulates viral replication fitness#261154bioRxiv / medRxiv
• Virucidal activity of porphyrin-based metal-organic frameworks against highly pathogenic coronaviruses and hepatitis C virus#330215HAL (France)
• Virucidal activity of porphyrin-based metal-organic frameworks against highly pathogenic coronaviruses and hepatitis C virus#330256HAL (France)
• Nicotinamide metabolism is essential for Hepatitis C Virus replication and the production of infectious Lipo-Viro-Particles#344602HAL (France)
• Missed opportunities for Hepatitis C Virus screening and care among persons hospitalized for injection-related infections.#472495NCBI PubMed Central
• Seroprevalence and risk factors of HBV/HCV/HIV triple co-infection among HIV patients receiving HAART at a Tertiary Hospital in Makurdi, Nigeria#1055408ULRR
• Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)#825350ClinicalTrials.gov
• TMC435-TiDP16-C108 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Digoxin and Between TMC435 and Rosuvastatin#884125ClinicalTrials.gov
• Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection#887224ClinicalTrials.gov
• MAGIA H3S Point of Care Test Performance for HIV, HBV, HCV, and Syphilis Screening in Pregnant Women in DR Congo#803098ClinicalTrials.gov
• Intraoperative pain sensitivity and aqueous humor inflammatory cytokine profiles in hepatitis C virus antibody-positive cataract patients.#255152NCBI PubMed Central
• The Nonstructural 5A Protein of Hepatitis C Virus Genotype 1b Does Not Contain an Interferon Sensitivity–Determining Region#315047HAL (France)
• Real-World Effectiveness of All-Oral Direct-Acting Antivirals in Patients With Hepatitis C Virus-Related HCC.#334925NCBI PubMed Central
• Pharmacokinetics of Sofosbuvir/Daclatasvir in HCV-infected Lactating Women#914856ClinicalTrials.gov
• Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and Ribavirin#1009449ClinicalTrials.gov
• NanoVirDetect - Nanostrukturiertes Elektrodensystem zur Detektion von Viren und Bakterien, Teilvorhaben: Herstellung des Mikrofluidiksystems mit integrierten Nanoelektrodenarrays : Schlußbericht ; Laufzeit des Vorhabens/Berichtszeitraum: 1.4.2001 - 31.3.2004#129757DataCite
• Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4#854324ClinicalTrials.gov
• A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD)#1045202ClinicalTrials.gov
• Understanding HCV Reinfection Rates in an Incarcerated Population After Cure With Interferon Free HCV Treatment#833473ClinicalTrials.gov
• Chronically-infected HCV Genotype 2 and 3 Treatment-naive Subjects: Part A: Safety and Efficacy of INX-08189 With Peg IFN Alfa-2a and Ribavirin. Part B: INX-08189 in Interferon Free Treatment With Daclatasvir and/or Ribavirin#1046504ClinicalTrials.gov
• An Efficacy, Safety and Pharmacokinetics Study of Simeprevir, Daclatasvir and Sofosbuvir in Participants With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver Disease#806353ClinicalTrials.gov
• Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C Virus#908489ClinicalTrials.gov
• Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter Study#912569ClinicalTrials.gov
• Perspectives of Caregivers of Kidney Transplant Recipients and Transplant Candidates About Kidneys From Donors With Hepatitis C Virus Infection.#323111NCBI PubMed Central
• Prediction of potential NS3-based T cell epitopes of hepatitis C virus by in-silico and in-vitro approach.#327010NCBI PubMed Central